Registro de ensayos clínicos multicéntricos internacionales de medicamentos en Rusia

 

Lista de estudios:

Estudiar 1:
  Título:                    A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Cáncer|Catarata|Baja densidad mineral ósea|osteopenia|Osteoporosis|Prostate Cancer
  Interventions:            Biológico: Denosumab|Biológico: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT00925600

Study 2:
  Título:                    Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Intra-Abdominal Infection
  Interventions:            Droga: Moxifloxacin (Avelox, BAY12-8039)|Droga: Ertapenem, Amoxicillin/clavulanate
  URL:                      http://ClinicalTrials.gov/show/NCT01069900

Study 3:
  Título:                    A Study of LY2140023 in Patients With Schizophrenia
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Schizophrenia
  Interventions:            Droga: LY2140023|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01307800

Study 4:
  Título:                    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Venous Thrombosis
  Interventions:            Droga: enoxaparina|Droga: warfarina|Droga: Placebo para apixabán|Droga: Placebo para enoxaparina|Droga: Placebo para warfarina|Droga: apixaban
  URL:                      http://ClinicalTrials.gov/show/NCT00643201

Study 5:
  Título:                    Lógica - Estudio de optimización de lapatinib en ErbB2 (HER2) Cáncer gástrico positivo: Una Fase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               o adenocarcinoma de la unión gastroesofágica que es irresecable debido a metástasis localmente avanzada, o Enfermedad localmente recurrente.|ErbB2 (HER2) Gástrico amplificado|Neoplasias, Tracto gastrointestinal|Esophageal
  Interventions:            Droga: lapatinib|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT00680901

Study 6:
  Título:                    Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Advanced Breast Cancer|Breast Cancer
  Interventions:            Droga: Neratinib|Droga: lapatinib|Droga: Capecitabine
  URL:                      http://ClinicalTrials.gov/show/NCT00777101

Study 7:
  Título:                    An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical or Urgent Invasive Procedure
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Reversal of Coagulopathy
  Interventions:            Biológico: Beriplex® P/N|Biológico: Fresh frozen plasma
  URL:                      http://ClinicalTrials.gov/show/NCT00803101

Study 8:
  Título:                    Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Relapsing Remitting Multiple Sclerosis
  Interventions:            Droga: Interferon β 1a|Droga: DAC HYP
  URL:                      http://ClinicalTrials.gov/show/NCT01064401

Study 9:
  Título:                    IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Metastatic Renal Cell Carcinoma
  Interventions:            Droga: Sunitinib|Biológico: IMA901 plus GM-CSF|Droga: Cyclophosphamide
  URL:                      http://ClinicalTrials.gov/show/NCT01265901

Study 10:
  Título:                    A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Schizophrenia
  Interventions:            
  URL:                      http://ClinicalTrials.gov/show/NCT01394601

Study 11:
  Título:                    Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Enfermedades cardiovasculares|Heart Diseases|Insuficiencia cardiaca, Congestive
  Interventions:            Droga: Aldosterone Antagonist (spironolactone)|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT00094302

Study 12:
  Título:                    Una fase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)
  Reclutamiento:              Recruiting
  Study Results:            No Results Available
  Conditions:               Enfermedad, Hodgkin
  Interventions:            Droga: brentuximab vedotin|Droga: placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01100502

Study 13:
  Título:                    Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Convulsiones|Epilepsia|Partial-Onset Seizures
  Interventions:            Droga: Retigabine IR
  URL:                      http://ClinicalTrials.gov/show/NCT01227902

Study 14:
  Título:                    A Rheumatoid Arthritis Study in Patients on a Background Treatment of Methotrexate
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Rheumatoid Arthritis
  Interventions:            Droga: LY2127399|Droga: Placebo every 2 semanas|Droga: Placebo every 4 weeks
  URL:                      http://ClinicalTrials.gov/show/NCT01198002

Study 15:
  Título:                    Study of Eniluracil + 5-Fluorouracil (5-fu) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Metastatic Breast Cancer
  Interventions:            Droga: Eniluracil|Droga: 5-Fluorouracil|Droga: Leucovorin|Droga: Capecitabine
  URL:                      http://ClinicalTrials.gov/show/NCT01231802

Study 16:
  Título:                    A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Tumor|Pain
  Interventions:            Droga: CG5503 ER|Droga: Placebo to match CG5503|Droga: Morphine Sulphate CR|Droga: Placebo to match Morphine Sulphate CR
  URL:                      http://ClinicalTrials.gov/show/NCT00472303

Study 17:
  Título:                    Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Rheumatoid Arthritis
  Interventions:            Droga: ATN-103|Droga: ATN-103
  URL:                      http://ClinicalTrials.gov/show/NCT01063803

Study 18:
  Título:                    A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Lymphocytic Leukemia, Chronic
  Interventions:            Droga: rituximab [MabThera]|Droga: rituximab [MabThera]|Droga: rituximab [MabThera]|Droga: Fludarabine|Droga: Cyclophosphamide
  URL:                      http://ClinicalTrials.gov/show/NCT01292603

Study 19:
  Título:                    A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Chronic Hepatitis B Virus, Pediatric
  Interventions:            Droga: Entecavir|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01079806

Study 20:
  Título:                    Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Alopecia|Androgenetic Alopecia
  Interventions:            Droga: 1mg Finasteride active|Droga: 0.02mg dutasteride|Droga: 0.1mg dutasteride|Droga: 0.5mg dutasteride|Droga: Finasteride placebo|Droga: Dutasteride placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01231607

Study 21:
  Título:                    Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Fibrilación auricular|Arritmia|Stroke Prevention|Mortality
  Interventions:            Device: Left atrial ablation|Droga: Rate or Rhythm Control Therapy
  URL:                      http://ClinicalTrials.gov/show/NCT00911508

Study 22:
  Título:                    Estudio de resultados cardiovasculares de alogliptina en sujetos con tipo 2 Diabetes and Acute Coronary Syndrome
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Diabetes mellitus, Tipo 2|Acute Coronary Syndrome
  Interventions:            Droga: Alogliptina|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT00968708

Study 23:
  Título:                    Evaluation of Tiotropium 2.5 y 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Asthma
  Interventions:            Droga: Placebo|Droga: Placebo|Droga: Placebo|Droga: Placebo|Droga: Placebo|Droga: 50 mcg salmeterol HFA MDI|Droga: 5 mcg tiotropium Respimat®|Droga: 2.5 mcg tiotropium Respimat®
  URL:                      http://ClinicalTrials.gov/show/NCT01172808

Study 24:
  Título:                    Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Droga: sorafenib|Biológico: mapatumumab
  URL:                      http://ClinicalTrials.gov/show/NCT01258608

Study 25:
  Título:                    Study Of Letrozole With Or Without PD 0332991 For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Breast Cancer
  Interventions:            Droga: PD 0332991|Droga: letrozole|Droga: letrozole
  URL:                      http://ClinicalTrials.gov/show/NCT00721409

Study 26:
  Título:                    Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Cáncer de pulmón - Non Small Cell
  Interventions:            Droga: Ipilimumab|Droga: Placebo|Droga: Paclitaxel|Droga: Carboplatin
  URL:                      http://ClinicalTrials.gov/show/NCT01285609

Study 27:
  Título:                    Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Alzheimer Disease
  Interventions:            Droga: bapineuzumab|Droga: bapineuzumab|Droga: placebo
  URL:                      http://ClinicalTrials.gov/show/NCT00667810

Study 28:
  Título:                    Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
  Reclutamiento:              Recruiting
  Study Results:            No Results Available
  Conditions:               B-Cell Chronic Lymphocytic Leukemia (B-CLL)
  Intervenciones:            Droga: Lenalidomide|Droga: Chlorambucil
  URL:                      http://ClinicalTrials.gov/show/NCT00910910

Study 29:
  Título:                    A Study of MabThera (Rituximab) in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia And Favorable Somatic Status
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Lymphocytic Leukemia, Chronic
  Interventions:            Droga: rituximab [MabThera]|Droga: fludarabina|Droga: cyclophosphamide
  URL:                      http://ClinicalTrials.gov/show/NCT01271010

Study 30:
  Título:                    A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Neoplasias, Breast
  Interventions:            Droga: lapatinib|Droga: trastuzumab|Droga: Aromatase inhibitor|Droga: lapatinib
  URL:                      http://ClinicalTrials.gov/show/NCT01160211

Study 31:
  Título:                    A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Osteoarthritis
  Interventions:            Droga: SD-6010|Droga: SD-6010|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT00565812

Study 32:
  Título:                    Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids
  Recruitment:              Not yet recruiting
  Study Results:            No Results Available
  Conditions:               Asthma
  Interventions:            Droga: Placebo matching Respimat|Droga: Placebo matching Respimat|Droga: BI 54903 Maryland|Droga: BI 54903 HD
  URL:                      http://ClinicalTrials.gov/show/NCT01458912

Study 33:
  Título:                    Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Heart Failure
  Interventions:            Droga: Placebo|Droga: Omecamtiv mecarbil
  URL:                      http://ClinicalTrials.gov/show/NCT01300013

Study 34:
  Título:                    Study of Immunotherapy to Treat Advanced Prostate Cancer
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Prostate Cancer
  Interventions:            Droga: Ipilimumab|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT00861614

Study 35:
  Título:                    Fase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Non-small Cell Lung Cancer
  Interventions:            Droga: Tavocept(BNP7787) in combination with cisplatin and either docetaxel or paclitaxel|Droga: Placebo in combination with cisplatin and docetaxel or paclitaxel
  URL:                      http://ClinicalTrials.gov/show/NCT00966914

Study 36:
  Título:                    An Efficacy, Seguridad, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Diabetes mellitus, Tipo 2|Renal Insufficiency
  Interventions:            Droga: Canagliflozin 100 mg|Droga: Canagliflozin 300 mg|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01064414

Study 37:
  Título:                    ACT-293987 in Pulmonary Arterial Hypertension
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Pulmonary Arterial Hypertension
  Interventions:            Droga: ACT-293987|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01106014

Study 38:
  Título:                    A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Rheumatoid Arthritis
  Interventions:            Droga: tocilizumab [RoActemra/Actemra]|Droga: tocilizumab [RoActemra/Actemra]|Droga: placebo|Droga: placebo|Droga: Disease-modifying antirheumatic drugs (FAME)
  URL:                      http://ClinicalTrials.gov/show/NCT01194414

Study 39:
  Título:                    Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (REAL ACADEMIA DE BELLAS ARTES)
  Reclutamiento:              Recruiting
  Study Results:            No Results Available
  Conditions:               Rheumatoid Arthritis
  Interventions:            Droga: Fostamatinib|Droga: Fostamatinib|Droga: Fostamatinib
  URL:                      http://ClinicalTrials.gov/show/NCT01242514

Study 40:
  Título:                    RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Insuficiencia cardiaca|Anemia|Enfermedad cardiovascular|Ventricular Dysfunction|Congestive Heart Failure
  Interventions:            Droga: Darbepoetin alfa|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT00358215

Study 41:
  Título:                    AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Non-Small Cell Lung Cancer
  Interventions:            Droga: bevacizumab [descubrí]|Droga: pemetrexed|Droga: cisplatin
  URL:                      http://ClinicalTrials.gov/show/NCT00961415

Study 42:
  Título:                    Study of ACT-129968 in Adult Patients With Partly Controlled Asthma.
  Reclutamiento:              Recruiting
  Study Results:            No Results Available
  Conditions:               Asthma
  Interventions:            Droga: ACT-129968|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01225315

Study 43:
  Título:                    A Study of Ixabepilone as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Endometrial Cancer
  Interventions:            Droga: Ixabepilone|Droga: Doxorubicin|Droga: Paclitaxel
  URL:                      http://ClinicalTrials.gov/show/NCT00883116

Study 44:
  Título:                    Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Kidney Neoplasms
  Interventions:            Droga: Axitinib (AG-013736)|Droga: Sorafenib
  URL:                      http://ClinicalTrials.gov/show/NCT00920816

Study 45:
  Título:                    A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Infección, Human Immunodeficiency Virus
  Interventions:            Droga: GSK1349572|Droga: Raltegravir|Droga: GSK1349572 Placebo|Droga: Raltegravir Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01231516

Study 46:
  Título:                    A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Hepatitis C
  Interventions:            Droga: PegIFN/RBV|Droga: BI 201335
  URL:                      http://ClinicalTrials.gov/show/NCT01330316

Study 47:
  Título:                    Effect of Multiple Infusions of AIN457 on Disease Activity in Relapsing-remitting Multiple Sclerosis
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Esclerosis múltiple|Relapsing-remitting
  Interventions:            Droga: AIN457|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01051817

Study 48:
  Título:                    A Study of the Efficacy and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1)
  Reclutamiento:              Recruiting
  Study Results:            No Results Available
  Conditions:               Chronic Idiopathic Urticaria
  Interventions:            Droga: omalizumab|Droga: placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01287117

Study 49:
  Título:                    Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Mycoses|Candidiasis, Invasive|Candidemia
  Interventions:            Droga: Isavuconazole|Droga: Caspofungin|Droga: Voriconazole
  URL:                      http://ClinicalTrials.gov/show/NCT00413218

Study 50:
  Título:                    BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Ovarian Neoplasms|Peritoneal Neoplasms
  Interventions:            Droga: BIBF 1120|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01015118

Study 51:
  Título:                    An Immunogenicity and Pharmacokinetics (PK) Study of DAC HYP Prefilled Syringe in Relapsing Remitting Multiple Sclerosis (RRMS)
  Reclutamiento:              Recruiting
  Study Results:            No Results Available
  Conditions:               Relapsing Remitting Multiple Sclerosis
  Interventions:            Biológico: Daclizumab High Yield Process prefilled syringe
  URL:                      http://ClinicalTrials.gov/show/NCT01462318

Study 52:
  Título:                    Study in Adolescents With Schizophrenia or Bipolar Disorder
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Trastorno bipolar I|Schizophrenia
  Interventions:            Droga: Olanzapine|conductual: Standard behavioral weight intervention|conductual: Intense behavioral weight intervention
  URL:                      http://ClinicalTrials.gov/show/NCT00982020

Study 53:
  Título:                    ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Coronary Artery Disease
  Interventions:            Droga: RVX000222|Droga: Placebo RVX000222
  URL:                      http://ClinicalTrials.gov/show/NCT01067820

Study 54:
  Título:                    A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307)
  Reclutamiento:              Recruiting
  Study Results:            No Results Available
  Conditions:               Schizophrenia
  Interventions:            Droga: RO4917838|Droga: RO4917838|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01235520

Study 55:
  Título:                    Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Subjects With PHPT Unable to Undergo Parathyroidectomy
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Hyperparathyroidism, Primary
  Interventions:            Droga: cinacalcet HCl|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT00975221

Study 56:
  Título:                    Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (REAL ACADEMIA DE BELLAS ARTES) Who Are Taking Methotrexate But Not Responding.
  Reclutamiento:              Recruiting
  Study Results:            No Results Available
  Conditions:               Rheumatoid Arthritis
  Interventions:            Droga: fostamatinib|Droga: fostamatinib|Droga: placebo, fostamatinib
  URL:                      http://ClinicalTrials.gov/show/NCT01197521

Study 57:
  Título:                    Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).
  Reclutamiento:              Recruiting
  Study Results:            No Results Available
  Conditions:               Convulsiones|Epilepsia|Partial-Onset Seizures
  Interventions:            Droga: Retigabine IR
  URL:                      http://ClinicalTrials.gov/show/NCT01336621

Study 58:
  Título:                    Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer.
  Reclutamiento:              Recruiting
  Study Results:            No Results Available
  Conditions:               Cáncer de mama metastásico|Metastases, Brain
  Interventions:            Droga: capecitabine|Droga: lapatinib|Droga: trastuzumab
  URL:                      http://ClinicalTrials.gov/show/NCT00820222

Study 59:
  Título:                    STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Myocardial Infarction
  Interventions:            Droga: tenecteplase|Droga: enoxaparin|Droga: clopidogrel|Procedimiento: catheterisation|Procedimiento: primary PCI
  URL:                      http://ClinicalTrials.gov/show/NCT00623623

Study 60:
  Título:                    A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Esclerosis múltiple, Relapsing-Remitting
  Interventions:            Droga: ocrelizumab|Droga: Rebif|Droga: ocrelizumab placebo|Droga: Rebif placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01247324

Study 61:
  Título:                    CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Diabetes mellitus, Tipo 2
  Intervenciones:            Droga: linagliptina|Droga: glimepiride
  URL:                      http://ClinicalTrials.gov/show/NCT01243424

Study 62:
  Título:                    PANORAMA Observational Study
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Arritmia|Cardiac Pacemaker, Artificial|Defibrillators, Implantable
  Interventions:            Device: Cardiac Pacemaker, Defibrillator, pacemaker lead
  URL:                      http://ClinicalTrials.gov/show/NCT00382525

Study 63:
  Título:                    GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Cáncer de pulmón de células no pequeñas con antígeno tumoral positivo|Cáncer de pulmón, Non-Small Cell
  Interventions:            Biológico: GSK1572932A Inmunoterapéutico contra el cáncer específico de antígeno|Biológico: Placebo Control
  URL:                      http://ClinicalTrials.gov/show/NCT00480025

Study 64:
  Título:                    A Study of the Quality of Life and Treatment Response to Once Weekly NeoRecormon (Epoetin Beta) Treatment in Anemic Patients With Solid and Lymphoid Malignancies.
  Reclutamiento:              Recruiting
  Study Results:            No Results Available
  Conditions:               Anemia
  Interventions:            Droga: epoetin beta [NeoRecormon]|Droga: epoetin beta [NeoRecormon]
  URL:                      http://ClinicalTrials.gov/show/NCT00776425

Study 65:
  Título:                    Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (warfarina) for the Treatment of Venous Thromboembolism (TEV) in Cancer
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Venous Thromboembolism
  Interventions:            Droga: warfarina|Droga: Innohep®
  URL:                      http://ClinicalTrials.gov/show/NCT01130025

Study 66:
  Título:                    Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               HIV
  Interventions:            Droga: HIV therapy
  URL:                      http://ClinicalTrials.gov/show/NCT01275625

Study 67:
  Título:                    LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Breast Neoplasms
  Interventions:            Droga: Afatinib 40mg once daily (OD)|Droga: Vinorelbine 25 mg/m2 weekly|Droga: Paclitaxel 80 mg/m2 weekly
  URL:                      http://ClinicalTrials.gov/show/NCT01271725

Study 68:
  Título:                    A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Patients With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung)
  Reclutamiento:              Not yet recruiting
  Study Results:            No Results Available
  Conditions:               Non-Small Cell Lung Cancer
  Interventions:            Droga: onartuzumab [MetMAb]|Droga: erlotinib [Tarčeva]|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01456325

Study 69:
  Título:                    Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Breast Cancer
  Interventions:            Biológico: ramucirumab (IMC-1121B)|Droga: docetaxel|Otro: placebo
  URL:                      http://ClinicalTrials.gov/show/NCT00703326

Study 70:
  Título:                    ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis -Extension Study
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Relapsing-remitting Multiple Sclerosis
  Interventions:            Droga: ACT-128800|Droga: ACT-128800|Droga: ACT-128800
  URL:                      http://ClinicalTrials.gov/show/NCT01093326

Study 71:
  Título:                    Un doble ciego, Controlado con placebo, 2-year Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease.
  Reclutamiento:              Recruiting
  Study Results:            No Results Available
  Conditions:               Enfermedad de Alzheimer|Demencia, Alzheimer Type
  Interventions:            Droga: Galantamina|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT00679627

Study 72:
  Título:                    A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS)
  Reclutamiento:              Recruiting
  Study Results:            No Results Available
  Conditions:               Psoriasis
  Interventions:            Biológico: ustekinumab/placebo|Biológico: ustekinumab/placebo|Biológico: ustekinumab/placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01090427

Study 73:
  Título:                    PEARL Schizophrenia Maintenance
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Schizophrenia
  Interventions:            Droga: lurasidona|Droga: Matching Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01435928

Study 74:
  Título:                    Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Preterm Birth
  Interventions:            Droga: Hydroxyprogesterone Caproate Injection, 250mg/mL|Droga: Vehicle
  URL:                      http://ClinicalTrials.gov/show/NCT01004029

Study 75:
  Título:                    A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Diabetes mellitus, Tipo 2
  Intervenciones:            Droga: aleglitazar|Droga: pioglitazone
  URL:                      http://ClinicalTrials.gov/show/NCT01043029

Study 76:
  Título:                    Roflumilast in Chronic Obstructive Pulmonary Disease (EPOC) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS)
  Reclutamiento:              Recruiting
  Study Results:            No Results Available
  Conditions:               Chronic Obstructive Pulmonary Disease
  Interventions:            Droga: Roflumilast|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01329029

Study 77:
  Título:                    A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+RO5072759 (GA101) in Patients With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Non-Hodgkin's Lymphoma
  Interventions:            Droga: bendamustine|Droga: RO5072759
  URL:                      http://ClinicalTrials.gov/show/NCT01059630

Study 78:
  Título:                    Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Asthma
  Interventions:            Droga: 2.5 mcg tiotropium Respimat|Droga: placebo Respimat|Droga: 2.5 mcg tiotropium Respimat
  URL:                      http://ClinicalTrials.gov/show/NCT01257230

Study 79:
  Título:                    TMC125IFD3002 - The VIOLIN Study: to EValuate Etravirine TolerabIlity, PharmacOkinetics With Other AntiretroviraLs In TreatmeNt Experienced Patients
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               HIV
  Interventions:            Droga: etravirine
  URL:                      http://ClinicalTrials.gov/show/NCT01422330

Study 80:
  Título:                    Study of Paclitaxel in Patients With Ovarian Cancer
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Cáncer de ovario epitelial|Cáncer peritoneal primario|Fallopian Tube Cancer
  Interventions:            Droga: Pacical®|Droga: Taxol®
  URL:                      http://ClinicalTrials.gov/show/NCT00989131

Study 81:
  Título:                    A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Ovarian Cancer
  Interventions:            Droga: bevacizumab [descubrí]|Droga: carboplatin|Droga: Paclitaxel
  URL:                      http://ClinicalTrials.gov/show/NCT01239732

Study 82:
  Título:                    Asthma in Children
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Asthma
  Interventions:            
  URL:                      http://ClinicalTrials.gov/show/NCT01286532

Study 83:
  Título:                    A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.
  Reclutamiento:              Recruiting
  Study Results:            No Results Available
  Conditions:               Rheumatoid Arthritis
  Interventions:            Droga: rituximab [MabThera/Rituxan]|Droga: Methotrexate
  URL:                      http://ClinicalTrials.gov/show/NCT00576433

Study 84:
  Título:                    A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Esclerosis múltiple, Relapsing-Remitting
  Interventions:            Droga: ocrelizumab|Droga: Rebif|Droga: ocrelizumab placebo|Droga: Rebif placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01412333

Study 85:
  Título:                    Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
  Reclutamiento:              Recruiting
  Study Results:            No Results Available
  Conditions:               Advanced or Metastatic Non-Small Cell Lung Cancer
  Interventions:            Droga: ABT-869|Droga: Placebo for ABT-869|Droga: ABT-869
  URL:                      http://ClinicalTrials.gov/show/NCT00716534

Study 86:
  Título:                    Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Lucrin Depot in Patients With Advanced Prostate Cancer in Russia
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Prostate Cancer
  Interventions:            
  URL:                      http://ClinicalTrials.gov/show/NCT01320735

Study 87:
  Título:                    A Study of the Safety and Efficacy of CNTO 328 in Combination With Best Supportive Care Compared to Best Supportive Care in Patients With Multicentric Castleman's Disease
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Castleman's Disease
  Interventions:            Otro: Placebo|Droga: CNTO 328
  URL:                      http://ClinicalTrials.gov/show/NCT01024036

Study 88:
  Título:                    Evaluation of SAR153191(REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Rheumatoid Arthritis
  Interventions:            Droga: SAR153191 (REGN88)|Droga: placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01061736

Study 89:
  Título:                    A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Kidney Transplantation
  Interventions:            Droga: Advagraf|Droga: Mycophenolate Mofetil|Droga: Simulect|Droga: Corticosteroids
  URL:                      http://ClinicalTrials.gov/show/NCT01304836

Study 90:
  Título:                    Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Mantle Cell Lymphoma
  Interventions:            Droga: Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone|Droga: Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone
  URL:                      http://ClinicalTrials.gov/show/NCT00722137

Study 91:
  Título:                    Un doble ciego, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               DLBCL
  Interventions:            Biológico: TL011|Biológico: Rituximab
  URL:                      http://ClinicalTrials.gov/show/NCT01205737

Study 92:
  Título:                    Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Breast Cancer
  Interventions:            Droga: sorafenib(nexavar, BAY43-9006) / Capecitabine|Droga: Placebo / Capecitabine
  URL:                      http://ClinicalTrials.gov/show/NCT01234337

Study 93:
  Título:                    A Study of RoActemra/Actemra (tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Enfermedad cardiovascular, Rheumatoid Arthritis
  Interventions:            Droga: tocilizumab [RoActemra/Actemra]|Droga: etanercept
  URL:                      http://ClinicalTrials.gov/show/NCT01331837

Study 94:
  Título:                    Pregabalin Versus Levetiracetam In Partial Seizures
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Partial Seizures
  Interventions:            Droga: pregabalin|Droga: levetiracetam
  URL:                      http://ClinicalTrials.gov/show/NCT00537238

Study 95:
  Título:                    A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Parkinson's Disease Psychosis
  Interventions:            Droga: pimavanserin tartrate (ACP-103)
  URL:                      http://ClinicalTrials.gov/show/NCT00550238

Study 96:
  Título:                    Estudio de exenatida del ensayo de reducción de eventos cardiovasculares (EXCEL): Un ensayo para evaluar los resultados cardiovasculares después del tratamiento con exenatida una vez a la semana en pacientes con tipo 2 Diabetes Mellitus
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Tipo 2 Diabetes Mellitus
  Interventions:            Droga: Exenatida una vez por semana|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01144338

Study 97:
  Título:                    A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Lupus eritematoso sistémico|Enfermedad del tejido conectivo|Autoimmune Disease
  Interventions:            Droga: LY2127399|Droga: Placebo every 2 semanas|Droga: Placebo every 4 weeks
  URL:                      http://ClinicalTrials.gov/show/NCT01205438

Study 98:
  Título:                    Study of FP-1039 in Subjects With Endometrial Cancers
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Endometrial Cancers With FGFR2 Mutations
  Interventions:            Droga: FP-1039
  URL:                      http://ClinicalTrials.gov/show/NCT01244438

Study 99:
  Título:                    TMC435HPC3007 - Phase III Trial of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Hepatitis C
  Interventions:            Droga: TMC435|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT01281839

Study 100:
  Título:                    Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy
  Recruitment:              Recruiting
  Study Results:            No Results Available
  Conditions:               Colorectal Cancer
  Interventions:            Droga: CS-7017|Droga: Placebo
  URL:                      http://ClinicalTrials.gov/show/NCT00986440

consultor de investigación científica

Interesado en saber si los programas clínicos actuales, desarrollos de investigacion, o enfoques terapéuticos emergentes pueden ser relevantes para su situación?

Información educativa y de investigación únicamente.. Las decisiones médicas individuales deben tomarse en consulta con profesionales sanitarios cualificados..


NB Ciencia

organización de investigación por contrato

WhatsApp